These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

923 related articles for article (PubMed ID: 26286340)

  • 21. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse Drug Reactions in a Tertiary Care Emergency Medicine Ward - Prevalence, Preventability and Reporting.
    Rydberg DM; Holm L; Engqvist I; Fryckstedt J; Lindh JD; Stiller CO; Asker-Hagelberg C
    PLoS One; 2016; 11(9):e0162948. PubMed ID: 27622270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective pharmacovigilance study in the infectious diseases unit of a tertiary care hospital.
    Karaismailoglu B; Saltoglu N; Balkan II; Mete B; Tabak F; Ozturk R
    J Infect Dev Ctries; 2019 Jul; 13(7):649-655. PubMed ID: 32065823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hospital: A Prospective Observational Cohort Study.
    Peter JV; Varghese GH; Alexander H; Tom NR; Swethalekshmi V; Truman C; Kumar TR; Sivakumar T
    Curr Drug Saf; 2016; 11(2):164-71. PubMed ID: 26916785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
    Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM
    Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.
    Passarelli MC; Jacob-Filho W; Figueras A
    Drugs Aging; 2005; 22(9):767-77. PubMed ID: 16156680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
    Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
    PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of adverse drug reactions in Jordan: a retrospective analysis of the National Pharmacovigilance Data Registry (2015-2021).
    Mhaidat NM; Alshogran OY; Altawalbeh SM; Jaber JM; Banat HA; Ahmad DS; Alabsi W
    Expert Opin Drug Saf; 2023; 22(10):957-965. PubMed ID: 37293991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.
    Patel H; Bell D; Molokhia M; Srishanmuganathan J; Patel M; Car J; Majeed A
    BMC Clin Pharmacol; 2007 Sep; 7():9. PubMed ID: 17894876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
    Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
    Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacovigilance in children in Camagüey Province, Cuba.
    Bárzaga Arencibia Z; López Leyva A; Mejías Peña Y; González Reyes AR; Fernández Manzano E; Choonara I
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1079-84. PubMed ID: 22315149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
    Adisa R; Adeniyi OR; Fakeye TO
    Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
    Svendsen K; Wood M; Olsson E; Nordeng H
    Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reactions amongst adult patients admitted in Lagos State University Teaching Hospital Lagos, Nigeria.
    Aderemi-Williams RI; Awodele O; Boyle CA
    Curr Drug Saf; 2015; 10(2):136-44. PubMed ID: 24909574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health care professionals knowledge and perception of pharmacovigilance in a tertiary care teaching hospital in Amman, Jordan.
    Abu Hammour K; El-Dahiyat F; Abu Farha R
    J Eval Clin Pract; 2017 Jun; 23(3):608-613. PubMed ID: 28090715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
    Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
    Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
    Yang W; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
    Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
    Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.